7th Symposium on Advances in Cancer Immunology and Immunotherapy

Chair: E. Stratikos (GR)

12.30-13.00 Exploiting the role of NK cells in cancer immunotherapy R. Solana (ES)
13.00-13.30 MDSC and immune evasion G. Pawelec (DE)
13.30-14.00 The role of antigen processing and presentation in the immunogenicity of cancer E. Stratikos (GR)
14.00-14.30 The role of B lymphocytes in solid tumours: opportunities for antibody immunotherapy S. Karagianni (GR)
14.30-14.50 Q&A

Chair: J. Wischhusen (DE)

14.50-15.20 Biomarkers as a tool for precision immuno-oncology: the prostate cancer paradigm M. Adamaki (GR)
15.20-15.50 Immune gene signatures as predictive/prognostic biomarkers for prostate cancer M. Goulielmaki (GR)
15.50-16.20 Cancer gene signatures predicting clinical outcomes during Immune checkpoint blockade D. Speiser (DE)
16.20-16.50 The emergence role of liquid biopsy in the era of cancer immunotherapy E. Lianidou (GR)
16.50-17.10 Q&A

Chair: C.N. Baxevanis (GR)

17.30-18.00 Update of the role of immunotherapy in Melanoma J. Duran Moreno (GR)

18.00-18.30 Τhe introduction of immunotherapy in the treatment of non-melanocyte skin cancers V. Papadopoulos (GR)
sponsored by Sanofi Genzyme

18.30-19.00 Head and neck carcinoma A. Psyrri (GR)

19.00-19.15 Q&A

Speaker: T. Whiteside (US)
Chair: A. Kotsakis (GR)
20:35-21:00 Q&A

Chair: C.N. Baxevanis (GR)

11.00-11.30 Mechanisms of immune resistance J. Wischhusen (DE)
11.30-12.00 miRNA - based regulation of tumor evolution B. Seliger (DE)
12.00-12.30 Immune activation strategies to achieve in situ tumor vaccination G. Adema (NL)
12.30-13.00 The host & microbiome crosstalk and its impact on tumorigenesis T. Frisan (SE)
13.00-13.20 Q&A

Chair: C.N. Baxevanis (GR)

15.00-15.30 Distinct immune signatures correlate with prognostication, treatment responses and MRD status in Multiple Myeloma I. Kostopoulos (GR)
15.30-16.00 Non-coding RNAs: Role and clinical utility in cancer immunity and immunotherapy M. Avgeris (GR)
16.00-16.15 Q&A

Chair: C.N. Baxevanis (GR)

16.15-16.45 The intratumoral immune landscape in breast cancer A. Giatromanolaki (GR)
16.45-17.15 Cellular composition and dynamic interactions intratumorally P. Foukas (GR)
17.15-17.45 Novel aspects for the intratumoral immune cellular compartmentalization in pancreatic cancer I. Pateras (GR)
17.45-18.15 The tumor microenvironment and mechanistic pathways for immune checkpoint blockade efficacy P. Verginis (GR)
18.15-18.30 Q&Α

Chair: A Kotsakis (GR)

18.50-19.20 Latest data on monotherapy in the 1st line of NSCLC K. Tsapakidis (GR)
sponsored by Sanofi Genzyme

19.20-19.50 Non small cell lung cancer D. Papadatos-Pastos (UK)

19.50-20.20 Small cell lung cancer D. Ziogas (GR)

20.20-20.30 Q&A

Speaker: S. Fortis (GR)
Chair: I.S. Pateras (GR)
21.00-21.30 Q&A

Chair: R. Tsitsilonis (GR)

11.00-11.30 Bispecific antibodies
11.30-12.00 Aspects of CD4+ T cell - based therapies for cancer E. Inderberg (NO)
12.00-12.30 Dendritic-cell based immunotherapy of ovarian cancer: results from phase II clinical trial J. Bartunkova (CZE)
12.30-12.45 Q&A

Chairs: V. Georgoulias (GR), A. Kotsakis (GR)

14.20-14.50 Urothelial carcinoma G.Tsironis (CY)
14.50-15.20 Breast carcinoma A. Matikas (SE)
15.20-15.50 The role of Immunotherapy in Gastrointestinal Tumors P. Papanastasopoulos (GR)
15.50-16.20 The State of the Art of Immunotherapy in Renal Carcinomas G. Lainakis (GR)
16.20-16.40 Q&A

Chair: C.N. Baxevanis (GR)

17.00-17.30 Novel vaccine for breast cancer L. Conti (IT)
17.30-18.00 TCR-gene modified T cells for cancer immunotherapy M. Nishimura (US)
18.00-18.10 Q&A

Speaker: A. Koumarianou (GR)
Chair: A. Kotsakis (GR)

Adamaki M.
Postdoctoral Research Associate · National Hellenic Research Foundation, Greece
Adema G.
Professor, Chair in Molecular Immunology, Radiotherapy & OncoImmunology laboratory, Department of Radiation Oncology RadboudUMC, Nijmegen, The Netherlands
Avgeris M.
Assistant Professor, Medical School, National and Kapodistrian University of Athens, Clinical Biochemistry Lab- Molecular Diagnostic, Greece
Bartunkova J.
Prof. MU, DrSc., Head, Institute of immunology, 2nd Faculty of Medicine, Motol University Hospital, Prague, Czech Republic
Baxevanis K.
PhD, Director of Cancer Immunology and Immunotherapy Center , Immunology Department, Saint Savvas Cancer Hospital
Conti L.
Assistant Professor in Immunology and General Pathology, Department of Molecular Biotechnology and Health Sciences, University of Turin, c/o Molecular Biotechnology Center, OncoImmunology group, Italy
Duran Moreno J.
Παθολόγος Ογκολόγος
Fortis S.
M.Sc, PhD, Postdoctoral Researcher, Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
Foukas P.
Frisan T.
Professor, Dept. Molecular Biology, Umeå Centre for Microbial Research (UCMR) Umeå University, Sweden
Georgoulias V.
Emeritus Professor of Medical Oncology, School of Medicine, University of Crete, Heraklion, Crete
Giatromanolaki A.
MD, Professor of Pathology, Democritus University of Thrace, Greece
Goulielmaki M.
PhD, Post-doctoral Researcher, Cancer Immunology and Immunotherapy Center, Saint Savas Hospital, Greece
Inderberg E.M.
Department of Cellular Therapy, Oslo University Hospital - The Norwegian Radium Hospital, Oslo, Norway
Karagiannis N.S.
Professor of Translational Cancer Immunology and Immunotherapy, St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London, UK
Kostopoulos I.
Postdoctoral researcher, Department of Biology, School of Science, National and Kapodistrian University of Athens, Greece
Kotsakis A.
MD, PhD, Associate Professor of Medical Oncology, School of Medicine, University of Thessaly, Director of the Department of Medical Oncology, Gener al University Hospital of Larissa, Larissa
Koukourakis M.
MD, Professor of Radiotherapy - Oncology, Democritus University of Thrace, Greece
Koumarianou A.
MD, PhD, ESY Director, Medical Oncologist, Hematology - Oncology Unit, 4th Department of Internal Medicine,“Attikon” University Hospital, Greece
Lainakis G.
Medical Oncologist, Deputy Director, D Oncology Clinic, Metropolitan Hospital, Greece
Lianidou E.
Professor of Analytical Chemistry - Clinical Chemistry, Analysis of Circulating Tumor Cells (ACTC) Lab, Dept of Chemistry, University of Athens, Athens, Greece
Liontos M.
PhD, Medical Oncologist, Consultant, Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece
Madrigal A.
MD, PhD, FRCP, FRCPath, DSc, HonDSci, FMedSci, Professor of Haematology, UCL Cancer Institute, Honorary Consultant, Royal Free NHS Trust, UCL Country Ambassador for México, UK
Matikas A.
Associate Professor of oncology, Karolinska Institutet, Stockholm, Sweden
Nishimura M.
Research, Department of Surgery, Stritch School of Medicine, Loyola University, Chicago, USA
Papadatos-Pastos D.
PhD, Consultant in Medical Oncology, Lung Cancer and Acute Oncology, University College London Hospitals The Princess Alexandra Hospital, UK
Papadopoulos V.
Medical Oncologist, University Hospital of Larissa, Larissa, Gr eece
Papanastasopoulos P.
MSc, PgDip (Onc), MRCP (Onc), CCT (UK), Consultant in Medical Oncology, Chemotherapy Unit, ‘St Andrew’s’, General Hospital of Patras, Greece
Pateras I.
Bsc, MD, PhD, Pathologist, Assistant Professor, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Pawelec G.
Professor of Experimental Immunology, Center of Medical Research, Second Department of Internal Medicine, University of Tubingen, Germany
Psyrri A.
MD, PhD, Medical Oncologist, Professor, Medical School, University of Athens, Greece
Seliger B.
Institute of Medical Immunology, Martin - Luther - University Halle - Wittenberg, Halle, Germany
Solana R.
Maimonides Biomedicine Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain
Speiser D.
Prof. Expert Group Immunology, Swiss National COVID-19 Science Task Force Department of Oncology, University of Lausanne Lausanne, Switzerland
Stratikos E.
Associate Professor, Biochemistry Department of Chemistry National and Kapodistrian University of Athens, Greece
Tsapakidis K.
MD, PhD, Medical Oncologist, Department of Oncology, University Hospital, Larisa, Greece
Tsironis G.
MD, PhD, Oncologist, Oncology Unit, Nicosia General Hospital, Cyprus
Verginis P.
Associate Professor Immunology and Biochemistry, Medical School, University of Crete, Heraklion, Crete
Whiteside T.
Professor of Pathology, Immunology and Otolaryngology, University of Pittsburgh Cancer Institute, USA
Wischhusen J.
PhD, Professor of Experimental Tumor Immunology, University of Würzburg School of Medicine, Department of Gynecology and Obstetrics, Finland
Ziogas D.
MD, PhD, Academic Scholar in Medical Oncology 1st Department of Internal Medicine, Laikon General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens

The certificate of attendance will be given to the participants at the end of the event.
Based on the latest circular of the National Drug Organization the Event is required to use an attendance tracking system. By the end of the event, a certificate will be given to those who have attended at least 60% of the total hours of the scientific Program.

Technical Support is available:
- everyday 09:00-17:00
- at the day of the event 09:00-21:00
For Technical Support please contact us:
Phone: +30 210 72 40 039
Email: support@livetime.gr

Event Details